Cullen/Frost Bankers’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40M Buy
86,753
+2,931
+3% +$1.48M 0.45% 48
2025
Q4
$47.5M Buy
83,822
+1,766
+2% +$940K 0.52% 42
2025
Q3
$36.7M Buy
82,056
+3,450
+4% +$1.66M 0.43% 50
2025
Q2
$42.7M Buy
78,606
+1,224
+2% +$640K 0.54% 45
2025
Q1
$38.3M Buy
77,382
+1,387
+2% +$767K 0.54% 44
2024
Q4
$39.7M Buy
75,995
+3
+0% +$1.56K 0.54% 42
2024
Q3
$37.3M Buy
75,992
+4,687
+7% +$2.18M 0.51% 43
2024
Q2
$31.7M Buy
71,305
+18,745
+36% +$7.47M 0.46% 52
2024
Q1
$21M Sell
52,560
-434
-0.8% -$164K 0.31% 88
2023
Q4
$17.9M Sell
52,994
-149
-0.3% -$44.4K 0.28% 91
2023
Q3
$15.5M Buy
53,143
+762
+1% +$238K 0.27% 94
2023
Q2
$17.9M Buy
52,381
+8,476
+19% +$2.56M 0.3% 85
2023
Q1
$11.2M Buy
43,905
+7,532
+21% +$1.86M 0.21% 122
2022
Q4
$9.65M Buy
36,373
+5,132
+16% +$1.25M 0.18% 137
2022
Q3
$5.86M Buy
31,241
+21,048
+206% +$4.52M 0.13% 152
2022
Q2
$2.05M Buy
10,193
+59
+0.6% +$13.8K 0.05% 229
2022
Q1
$3.06M Buy
10,134
+5
+0% +$1.46K 0.06% 216
2021
Q4
$3.64M Sell
10,129
-413
-4% -$142K 0.07% 208
2021
Q3
$3.49M Sell
10,542
-96
-0.9% -$32.2K 0.07% 207
2021
Q2
$3.26M Sell
10,638
-312
-3% -$87.5K 0.07% 214
2021
Q1
$2.7M Sell
10,950
-24
-0.2% -$6.04K 0.06% 225
2020
Q4
$2.99M Sell
10,974
-1,590
-13% -$395K 0.07% 203
2020
Q3
$2.97M Buy
12,564
+33
+0.3% +$7.41K 0.07% 190
2020
Q2
$2.38M Buy
12,531
+816
+7% +$146K 0.06% 209
2020
Q1
$1.93M Sell
11,715
-33
-0.3% -$6.04K 0.07% 205
2019
Q4
$2.31M Sell
11,748
-750
-6% -$140K 0.06% 211
2019
Q3
$2.25M Buy
12,498
+3
+0% +$519 0.07% 202
2019
Q2
$2.18M Buy
12,495
+24
+0.2% +$4.11K 0.07% 192
2019
Q1
$2.37M Buy
12,471
+81
+0.7% +$14.4K 0.07% 184
2018
Q4
$1.98M Sell
12,390
-135
-1% -$22.9K 0.07% 190
2018
Q3
$2.4M Buy
12,525
+450
+4% +$79.9K 0.07% 187
2018
Q2
$1.93M Sell
12,075
-141
-1% -$21.5K 0.06% 198
2018
Q1
$1.68M Sell
12,216
-60
-0.5% -$8.37K 0.05% 214
2017
Q4
$1.49M Sell
12,276
-765
-6% -$95.7K 0.05% 219
2017
Q3
$1.52M Buy
13,041
+945
+8% +$103K 0.05% 216
2017
Q2
$1.26M Sell
12,096
-18
-0.1% -$1.73K 0.04% 229
2017
Q1
$1.03M Sell
12,114
-1,404
-10% -$111K 0.04% 242
2016
Q4
$953K Hold
13,518
0.03% 242
2016
Q3
$1.09M Sell
13,518
-342
-2% -$26.2K 0.04% 235
2016
Q2
$1.02M Sell
13,860
-900
-6% -$63.3K 0.04% 240
2016
Q1
$985K Sell
14,760
-450
-3% -$27.9K 0.04% 237
2015
Q4
$923K Sell
15,210
-468
-3% -$26.3K 0.03% 237
2015
Q3
$801K Buy
15,678
+1,755
+13% +$99.4K 0.03% 252
2015
Q2
$749K Sell
13,923
-126
-0.9% -$7.05K 0.03% 264
2015
Q1
$788K Sell
14,049
-405
-3% -$22.9K 0.03% 265
2014
Q4
$849K Sell
14,454
-450
-3% -$25.1K 0.03% 264
2014
Q3
$765K Sell
14,904
-1,314
-8% -$65.2K 0.03% 263
2014
Q2
$742K Sell
16,218
-7,875
-33% -$347K 0.03% 265
2014
Q1
$1.17M Sell
24,093
-675
-3% -$31.8K 0.05% 229
2013
Q4
$1.06M Sell
24,768
-2,169
-8% -$91.3K 0.05% 238
2013
Q3
$1.13M Sell
26,937
-513
-2% -$22.7K 0.06% 226
2013
Q2
$1.54M Buy
+27,450
New +$1.51M 0.08% 196

Other funds holding ISRG

Cullen/Frost Bankers's ISRG Position: Q1 2026 in Review

Cullen/Frost Bankers increased its Intuitive Surgical (ISRG) stake by 3.5% in Q1 2026, buying an estimated $1.48M and bringing the position to 86,753 shares worth $40M. The position accounts for 0.45% of the portfolio, ranked #48.

Cullen/Frost Bankers first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.5M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Cullen/Frost Bankers held 86,753 shares of Intuitive Surgical worth $40M as of Q1 2026.
  • Cullen/Frost Bankers bought 2,931 Intuitive Surgical shares in Q1 2026, an estimated $1.48M.
  • Intuitive Surgical made up 0.45% of Cullen/Frost Bankers's portfolio in Q1 2026, its #48 holding.
  • Cullen/Frost Bankers first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
  • Cullen/Frost Bankers's Intuitive Surgical position peaked at $47.5M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.